Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISPERIDONE vs RITUXIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RISPERIDONE vs RITUXIMAB: Safety Overview

Metric RISPERIDONE RITUXIMAB
Total FAERS Reports 79,288 178,614
Deaths Reported 4,120 28,910
Death Rate 5.2% 16.2%
Hospitalizations 18,771 54,631
Average Patient Age 31.9 yrs 54.6 yrs
% Female Patients 15.6% 64.3%
FDA Approval Date Apr 12, 2007 N/A
Manufacturer NuCare Pharmaceuticals, Inc. Genentech, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription